IMIngrid Fernandes Mathias‐Santamaria

Ingrid Fernandes Mathias‐Santamaria

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Ingrid Fernandes Mathias‐Santamaria has a total of 40 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Treatment of single gingival recessions using iPRF‐biofunctionalized collagen matrix: A randomized clinical trial

    by Mauro Pedrine Santamaria, Amanda Rossato, Manuela Maria Viana Miguel, Ana Carolina Ferreira Bonafé, Ingrid Fernandes Mathias‐Santamaria, Marcelo Pereira Nunes

    Background: The biofunctionalization of collagen matrices (CMs) with injectable platelet‐rich fibrin (i‐PRF) has been proposed to enhance their bioactivity and clinical efficacy in the treatment of gingival recessions (GRs). This study evaluated the use of a volume‐stable collagen matrix (VCMX) biofunctionalized with i‐PRF as an adjunct to the coronally advanced flap (CAF) for single GRs. Methods: Seventy‐five patients with single RT1 GR were randomly assigned to CAF, CAF+VCMX, or CAF+VCMX+iPRF. Clinical, esthetic, and patient‐centered outcomes were assessed at baseline and at 6 months. Results: All groups resulted in significant recession reduction (CAF: 1.93 ± 0.86 mm; CAF+VCMX: 1.64 ± 0.68 mm; CAF+VCMX+iPRF: 1.70 ± 0.84 mm), with no statistically significant differences among groups ( p = 0.36). Groups treated with VCMX showed greater gingival thickness (GT) gain (CAF: 0.18 ± 0.25 mm; CAF+VCMX: 0.39 ± 0.26 mm; CAF+VCMX+iPRF: 0.45 ± 0.29 mm), favoring CAF+VCMX+iPRF ( p < 0.001). No significant keratinized tissue width (KTW) gain was observed ( p > 0.05). Adjusted models identified baseline KTW and KTW gain as positive predictors of complete root coverage (CRC), and KTW gain as the main predictor for RecRed and %RC. Conclusions: All approaches were effective in reducing GR and improving clinical parameters. The iPRF addition to the VCMX may not improve root coverage outcomes (NCT05916742). Plain language summary: Gingival recession, or receding gums, occurs when the gum moves away from the tooth, exposing the root of the tooth. This can cause sensitivity and esthetic concerns and increase the tooth's susceptibility to problems. A common surgical treatment is the coronally advanced flap (CAF), which repositions the gum to cover the exposed root. In some cases, dentists add a collagen matrix to help thicken the gum and to improve the outcome. A newer option enhances this matrix with a patient's own blood product called injectable platelet‐rich fibrin (i‐PRF), which may improve healing. This study included 75 patients with a single recession defect. They were randomly assigned to one of three treatments: CAF alone, CAF with a collagen matrix, or CAF with a collagen matrix enhanced with i‐PRF. After 6 months, all treatments led to similar improvements in root coverage, sensitivity, and esthetics. However, patients who received the collagen matrix, especially when combined with i‐PRF, developed thicker gum tissue. Thicker and wider gum tissue is associated with better long‐term outcomes. All procedures were well tolerated and caused minimal discomfort. Overall, adding a collagen matrix, particularly when enhanced with i‐PRF, may support thicker gums and help to maintain long‐term results.


  • Salivary NLRP3 inflammasome as a promising biomarker for palatal mucosa healing in diabetes mellitus: A pilot study

    by Manuela Maria Viana Miguel, Ana Carolina Ferreira Bonafé, Ingrid Fernandes Mathias‐Santamaria, D. Travis Thomas, Luciana Macchion Shaddox, Mauro Pedrine Santamaria

    Background: The NOD‐like receptor family pyrin domain‐containing protein 3 (NLRP3) inflammasome is a protein complex that regulates IL‐1β activation. Despite its known role in dermal healing, its involvement in oral mucosal healing remains poorly understood. Methods: Twenty‐four subjects, including 12 with Type 2 diabetes mellitus (T2DM) and 12 normoglycemic controls (C), underwent a surgical procedure for mucogingival defect treatment in which a graft was harvested from the palate. The palatal wound was assessed for remaining wound area (RWA) and epithelialization (EPT) until 3 months. Wound exudate was collected on days 3 and 7 post‐operatively to analyze inflammatory biomarkers, proteinases, and growth factors. NLRP3, PYCARD, CASPASE‐1, and interleukin‐1beta (IL‐1β) salivary levels were assessed preoperatively and 7 days post‐surgery. Results: Lower EPT rates and greater RWA were observed in T2DM compared to Control on days 7 and 14 postoperatively. Higher MMP‐9 concentration was detected in T2DM subjects on days 3 and 7 post‐surgery ( p < 0.05). Salivary NLRP3 and PYCARD increased in the C group at 7 days post‐surgery ( p ≤ 0.04), whereas IL‐1β was higher over time in the T2DM group ( p = 0.003). At baseline, NLRP3 and PYCARD levels were higher in T2DM ( p ≤ 0.005), whereas PYCARD ( p = 0.01) and CASPASE‐1 ( p = 0.05) remained elevated at 7 days compared with C. A positive association between salivary NLRP3 levels with IL‐1β ( r = 0.46) and tumor necrosis factor‐alpha (TNF‐ α ) ( r = 0.47) from wound exudate on day 7 was observed. PYCARD levels associated with IL‐1β ( r = 0.48) and TNF‐ α ( r = 0.50) at the same time point. Principal component analysis of inflammasome‐related markers and wound biomarkers on day 7 suggested a potential impact on delayed wound closure by day 14. Conclusion: The NLRP3 inflammasome may be a promising biomarker for T2DM‐related acute palatal healing due to its early upregulation and association with proinflammatory markers, with a potential impact on delayed wound closure.

  • Charcoal‐Containing Dentifrice Effect on Resin Composite Roughness at 6‐Month Simulated Brushing

    by Lauren Eckert, Ingrid Fernandes Mathias‐Santamaria, Howard Roberts

    Background: Charcoal dentifrices are marketed as an alternative to whitening treatments. However, there is a lack of evidence that supports its effect, as well as potential abrasive wear. This study's objective was to evaluate the roughness of a nano‐hybrid resin composite during six months of simulated toothbrushing using a charcoal‐containing toothpaste, a conventional toothpaste, and a control group using deionised water. Methods: Sixty maxillary and mandibular extracted molars were prepared and restored with a nano‐hybrid resin composite, with specimens divided into three groups ( n = 20): A charcoal‐containing toothpaste, a conventional toothpaste, and a distilled water control. Simulated toothbrushing was accomplished with dentifrice slurry at 200 g‐force for 120 cycles per minute for a total of 5,000 cycles, which was equivalent to six months of normal toothbrush use. Specimens were scanned with a laser microscope at baseline and after simulated brushing, with roughness recorded. Results: No difference ( p = 0.6189) was identified between the groups regarding restoration surface roughness before simulated brushing. Significantly greater ( p = 0.0323) roughness after brushing was identified with the charcoal toothpaste as compared to the similar ( p > 0.9999) conventional toothpaste and distilled water control. Comparison of roughness before and after brushing within each group identified no significant roughness differences within the distilled water (p = 0.5825) and conventional toothpaste ( p = 0.5915) groups, while a significant difference ( p = 0.0147) was found within the charcoal toothpaste group. Conclusion: Under the conditions of this study, a charcoal‐containing toothpaste caused significantly more resin composite surface roughness as compared to a conventional toothpaste and distilled water control.

  • Top Cited Papers

    An updated evidence‐based recommendation for the treatment of gingival recession associated with non‐carious cervical lesions

    by Mauro Pedrine Santamaria, Ingrid Fernandes Mathias‐Santamaria, Lorenzo Tavelli, Shayan Barootchi, Giovan Paolo Pini Prato

    Background: Approximately 50% of the gingival recessions (GRs) are associated with non‐carious cervical lesions (NCCLs), forming what are known as combined defects (CDs), which often require specific treatment protocols that differ from those used for GRs on teeth with an intact and sound surface. This narrative review aims to evaluate the current and relevant literature on the treatment of CDs and update the latest decision‐making process with the new literature. Methods: Medline/PubMed, Embase, BIREME, and Google Scholar databases were searched. The NCCL portion of the CDs was classified according to Pini‐Prato et al.’s classification (2010). The GR portion of the CDs was classified according to Cairo et al.’s classification (2011) and gingival phenotype. Based on these, a decision tree, supported by the current literature, was proposed. Results: Several approaches associating different surgical techniques/graft materials with different NCCL restoration protocols and materials are available. When A−, A+, and B− NCCL are present, only a surgical procedure for root coverage is needed based on GR characteristics. When either B+ or V‐shaped NCCL is present, a composite restorative protocol and a root coverage procedure should be considered. Conclusions: CDs are characterized by the coexistence of gingival recession and a non‐carious cervical lesion. This updated decision‐making process incorporated current literature, including new evidence on soft tissue grafts, which can guide clinicians in the treatment of CDs. Plain language summary: Gum recession often occurs alongside defects in the tooth that are not caused by cavities. These two conditions can appear on the same tooth in about half of the cases. When that happens, treatment becomes more complex and requires careful planning. Choosing the best approach depends on the shape and severity of the tooth defect. This recommendation helps dentists and patients understand how to manage these combined problems. Most cases fall into mild categories (A−, A+, and B−; i.e., shallow tooth defects) and can be treated with standard procedures for gum recession alone. However, about 25% of cases have a more advanced defect (B+; i.e., deep tooth defects), which requires both a tooth restoration and gum surgery. The way gum recession is treated also depends on how thick the gum tissue is. If the tissue is thin, using the patient's own tissue for a graft usually gives the best results. If the tissue is already thick, a graft may not be necessary. In moderate cases, a graft using either patient tissue or commercial materials can improve long‐term success. This recommendation summarizes the latest research and provides practical guidance to improve treatment outcomes for both patients and clinicians.


  • Aumento do fenótipo do tecido mole peri-implantar em área previamente acometida por peri-implantite: relato de caso com acompanhamento de três anos

    by Ana Carolina Ferreira Bonafé, Amanda Rossato, Ingrid Fernandes Mathias-Santamaria, Lucas Raineri Capeletti, Mauro Pedrine Santamaria, Marcelo Pereira Nunes

    Paciente, sexo feminino, com 66 anos de idade, foi encaminhada com o objetivo de tratar a peri-implantite e melhorar a estabilidade dos tecidos ao redor dos implantes 25 e 26. A cirurgia com EGL foi conduzida após tratamento cirúrgico da peri-implantite e consistiu na realização do retalho posicionado apicalmente com EGL. A profundidade de sondagem (PS), índice da mucosa implantar (IMI), índice gengival modificado (IGm), índice de placa modificado (IPm), espessura da mucosa (EM), largura de TQ e recessão da mucosa peri-implantar (RMP). Alem disso, foi utilizado o escore estético rosa: papilas mesial (PM) e distal (PD), nível e contorno do tecido mole (NMT), deficiência do processo alveolar (DPA), e cor (CT) e textura (TT) do tecido foram avaliados inicialmente. Apos 3 anos, o implante #25 apresentou aumento de EM (1 mm para 2 mm) e TQ (0,5 mm para 2 mm), com redução da RMP (0,5 mm para 0 mm). Houve melhora na NMT (discrepância maior para ausência), CT (pouco natural para natural), cor e TT (diferença obvia para nenhuma diferença), enquanto PM e PD se mantiveram estáveis. A DPA mostrou melhora radiográfica. Para o implante 26, observou-se aumento de EM (1 mm para 2 mm) e TQ (0,5 mm para 2 mm), e redução da RMP (1,5 mm para 1 mm). Houve melhora em NMT (discrepância maior para menor), CT (pouco natural para natural), cor e TT (diferença obvia para nenhuma diferença), enquanto PM manteve-se ausente. A DPA também permaneceu leve. Os sítios atingiram PS ≤ 5 mm, IMI = 0, IGm = 1, IPm = 0 ao final do tratamento da peri-implantite e mantiveram estabilidade. O enxerto gengival livre (EGL) foi eficaz na modificação do fenótipo em sitio com histórico de peri-implantite, promovendo aumento de espessura e largura do tecido queratinizado, mantendo-se estável após três anos. Palavras-chave: Implantes Dentarios, Estética, Peri-implantite, Terapia de Tecidos Moles, Tecido Conjuntivo.

  • Volume‐stable collagen matrix to treat gingival recession associated with non‐carious cervical lesions: Randomized clinical trial

    by Mauro Pedrine Santamaria, Manuela Maria Viana Miguel, Amanda Rossato, Ana Carolina Ferreira Bonafé, Isabel Vasconcellos de Souza, Thiago Marchi Martins, Marcelo Pereira Nunes, Ingrid Fernandes Mathias‐Santamaria

    Background: Collagen matrices (CMs) have been used for the treatment of gingival recession defects. A new volume‐stable collagen matrix (VCMX) was developed focused on enhancing tissue thickness due to a cross‐linked collagen structure. Thus, the present randomized clinical trial aims to evaluate clinical and patient‐centered parameters in the treatment of gingival recession (GR) RT1 associated with non‐carious cervical lesions (NCCL) B+ partially restored using coronally advanced flap (CAF) alone or CAF and VCMX. Methods: Forty patients diagnosed with GR RT1 plus NCCL B+ were treated with partial restorations (composite apical margin 1 mm beyond the estimated level cement–enamel junction), followed by CAF alone or with VCMX. Clinical, patient‐related outcomes and esthetic measurements were assessed after 6 months. The recession reduction (RecRed) was the primary outcome. Results: CAF and CAF+VCMX provided significant RecRed (1.87 vs. 1.78 mm; p = 0.76) and combined defect coverage (%CDC: 50.95 vs. 48.64%, p = 0.60) after 6 months. No difference was observed regarding the estimated root coverage (73.54 vs. 69.65%, p = 0.75). Greater gingival thickness (GT) gain was observed with VCMX (0.43 vs. 0.15 mm, p = 0.003). Both treatments decreased dentin hypersensitivity, achieved aesthetic satisfaction, and provided similar patient comfort. Keratinized tissue width is an important predictor for root coverage success while VCMX depends on it for greater RecRed (β = 1.775; p = 0.004). Combined defect (CD) height and depth can have both positive and negative impacts on coverage parameters. Conclusions: Both therapies provided significant CD coverage and RecRed, with no superiority of CAF+VCMX over CAF. However, VCMX led to a higher GT gain after 6 months (NCT05916716; IRB:46852621.0.0000.0077). Plain Language Summary: Combined defects (CDs), where gingival recession (GR) is associated with non‐carious cervical lesions (NCCL), represent a clinical condition that clinicians frequently encounter. The lack of treatment worsens dentin hypersensitivity (DH) and esthetic perceptions. Some CDs require a surgical‐restorative protocol. To date, partial restorative fillings combined with a coronally advanced flap (CAF), and connective tissue graft (CTG) surgical technique is considered the most predictable approach; however, the use of CTG has some drawbacks, including the risk of bleeding and patient discomfort. The use of collagen matrices (CMs) as an alternative to CTG has been assessed in the literature. This study aimed to evaluate a cross‐linked collagen matrix (VCMX) in the treatment of GR/RT1 associated with NCCL/B+ partially restored. Despite similar recession reduction and combined defect coverage of up to 6 months, the VCMX promoted a greater increase in gingival thickness (GT) (0.43 mm). This is a crucial parameter for maintaining long‐term clinical outcomes. Patient comfort and reduced analgesic intake in both groups display the clinical benefit against autogenous grafts. However, achieving satisfactory outcomes with VCMX requires adequate soft tissue features before surgery, such as a larger keratinized tissue width. While both treatments performed similarly, the higher GT gain was observed with VCMX.


  • Guided‐modified coronally advanced flap: Novel digital approach to treat multiple gingival recessions. Workflow and case study

    by Mauro Pedrine Santamaria, Ana Carolina Ferreira Bonafé, Amanda Rossato, Manuela Maria Viana Miguel, Andrews Porto da Costa, Ingrid Fernandes Mathias‐Santamaria, Marcelo Pereira Nunes, Lucas Araújo Queiroz

    Background: Gingival recession (GR) poses esthetic and functional challenges for patients, particularly in cases of multiple adjacent defects. Traditional surgical approaches, such as the modified coronally advanced flap (MCAF) with connective tissue grafts (CTG), demand high levels of precision and skill, making outcomes reliant on clinician expertize. The integration of digital technologies, including cone‐beam computed tomography (CBCT) and computer‐aided design and manufacturing (CAD–CAM), offers a novel, standardized approach to enhance procedural accuracy and predictability. Methods: This case study describes the use of the guided‐modified coronally advanced flap (g‐MCAF) for the treatment of multiple GR defects. A patient whose main concern was the esthetic appearance of her teeth was treated. Using an intraoral scanner, CBCT data, and CAD‐CAM software, surgical guides were designed and 3D printed using a dedicated resin, assuring precise adaptation to the patients’ teeth. The guides delineated MCAF oblique incisions and free gingival graft dimensions tailored to fit into the area, facilitating flap design, and graft harvesting. Results: The guided MCAF (g‐MCAF) procedure successfully achieved complete root coverage. At the 6‐month follow‐up, recession reduction was observed, measuring 2.22 mm for tooth #5, 2.59 mm for tooth #6, and 2.26 mm for tooth #7. Gingival thickness also increased, reaching 1.23, 1.16, and 1.45 mm, respectively. Additionally, the patient reported improved esthetics and reduced hypersensitivity. Conclusion: The g‐MCAF technique may have the potential to serve as a reliable aid to execute MCAF in the management of multiple GR defects. Key points: A guided surgical approach (g‐MCAF) using digital technologies allows for precise flap design and graft harvesting, which may help control variability and minimize errors during root coverage procedures. The integration of CBCT, intraoral scanning, and CAD–CAM technologies supports preoperative planning, potentially contributing to safer and more predictable outcomes, particularly in cases requiring connective tissue grafts. This innovative approach may assist in simplifying complex surgical techniques, improving clinician confidence, and serving as both a clinical and an educational tool for periodontal plastic surgery.


  • Omega‐3 and aspirin in the nonsurgical treatment of grade C periodontitis: A randomized clinical trial

    by Cássia F. Araujo, Naira M. R. B. Andere, Nidia C. Castro dos Santos, Laís F. F. Ferraz, Manuela M. V. Miguel, Ingrid F. Mathias‐Santamaria, Mabelle F. Monteiro, Luciana M. Shaddox, Renato C. V. Casarin, Mauro P. Santamaria

    Background: The use of omega‐3 (Ω‐3) polyunsaturated fatty acids and acetylsalicylic acid (ASA, aspirin) has shown better clinical outcomes in the treatment of periodontitis compared to nonsurgical periodontal therapy (NSPT) alone. This randomized clinical trial aimed to evaluate the use of 900 mg Ω‐3 and 100 mg ASA for 180 days as adjuncts to NSPT for generalized stage III–IV grade C periodontitis (GCP).Methods: Patients underwent subgingival debridement (SD) associated with Ω‐3+ASA or cellulose placebo and received monthly prophylaxis. Clinical and immunological parameters were compared at baseline, 3, and 6 months after treatment. The daily dose of Ω‐3 consisted of 540 mg eicosapentaenoic acid (EPA) and 360 mg docosahexaenoic acid (DHA).Results: Thirty‐eight patients, 12 males (7 in the SD+Ω‐3+AAS group and 5 in the SD+Placebo group; p > 0.05), with a mean age of 32.84 ± 5.47 and 30.42 ± 5.79 years, respectively (p > 0.05), were included. Both groups showed significant improvements (p < 0.05) in all full‐mouth parameters. Reductions in the number of pockets, mean probing depth (PD), and clinical attachment level of moderate and deep sites, as well as the number and percentage of residual pockets, were observed (intragroup p < 0.05; intergroup p > 0.05). However, residual pockets' mean PD decrease (p < 0.05) was only observed at 6 months in the SD+Ω‐3+ASA group. The concentration of interleukin (IL)‐1β from moderate and deep pockets decreased (p < 0.05) in both groups. The matrix metalloproteinase (MMP)‐9 to tissue metalloproteinase inhibitor (TIMP)‐1 ratio in the SD+Placebo group at 3 months revealed a proinflammatory profile in moderate (intergroup p = 0.006) and deep pockets (intergroup p < 0.001).Conclusion: Ω‐3+ASA therapy did not add clinical benefits to the NSPT for generalized stage III–IV GCP, although some immunomodulatory benefits could be observed.Plain Language Summary: The use of omega‐3 (Ω‐3) and aspirin (ASA) along with subgingival debridement (SD) for root decontamination of periodontal pockets has shown better results in the nonsurgical treatment of gum disease and bone loss compared to SD alone. This investigation aimed to evaluate the use of 900 mg Ω‐3 and 100 mg ASA for 180 days as adjuncts to the treatment of patients with gum disease and rapid bone loss rate. Thirty‐eight patients underwent SD associated with Ω‐3+ASA or placebo. Clinical and immunological parameters were evaluated at the beginning of the study and 3 and 6 months after. Both groups showed significant improvements. A significant reduction in the number of sites with diseased pockets was observed. The number of residual diseased sites was also significantly reduced, without differences between the groups. However, a significant decrease in the pocket size of the diseased sites was only observed at 6 months in the group that received Ω‐3+ASA. The concentration of interleukin (IL)‐1β (a protein present in the inflammatory process) from diseased sites significantly decreased in both groups. We concluded that the proposed therapy did not add any significant clinical benefits for patients with gum disease and rapid bone loss rate.


  • Microbiome and Inflammatory Biomarkers Associated With Palatal Wound Healing

    by Mauro Pedrine Santamaria, Ingrid Fernandes Mathias‐Santamaria, Ana Carolina Ferreira Bonafé, Octavio A. Gonzalez, Sreenatha Kirakodu, Mabelle de Freitas Monteiro, Renato Corrêa Vianna Casarin, Luciana Macchion Shaddox, Manuela Maria Viana Miguel

    Aim: The clinical outcomes of a variety of surgical procedures highly depend on tissue repair and show high variability among patients. There is a gap in the literature on how the host inflammatory response, the microbiome, and the interplay between them can influence oral mucosa healing. In this pilot study, we aimed to evaluate the microbiome and biomarkers profiles in patients who had desired versus undesired wound healing in the palatal mucosa.Methods: Seventeen patients underwent a free gingival graft (FGG) for socket preservation. Palatal wound closure (WC) and epithelization (EPT) were assessed clinically. Biofilm from the palatal wound was collected before the surgical procedure and 3, 7, 14, and 30 days postoperatively. The inflammatory exudate was sampled on Days 3 and 7. At 14 days posttreatment, patients were classified into two groups based on EPT rates: (1) undesired healing (UH) and (2) desired healing (DH).Results: No difference was observed in alfa diversity over time or between groups. In beta diversity, both UH and DH showed microbiome changes on Days 3–7 and 7, respectively, compared with the baseline (p = 0.01), returning to its initial condition 30 days later. There was a trend toward a different microbiome profile between groups on Day 7 (p = 0.08). Bacterium composition in DH showed a balance between healthy species and oral pathogens over time, whereas UH composition was characterized by microorganisms correlated with epithelium invasion/cytotoxicity; virulence factor upregulation; and oral diseases, such as periodontitis and aphthous stomatitis, until Day 30. UH showed an increase in IL‐6, MCP‐1, and MIP‐1α over time, and DH showed a decrease in TIMP‐1, IL‐1β, and MIP‐1α. On Days 3 and 7, MIP‐1α and MMP‐2 showed greater concentrations of DH in the intergroup assessment, and MCP‐1 increased on Day 7 in UH.Conclusion: Specific microbiome/inflammatory profiles are associated with DH and UH.Trial Registration: NCT05171400


  • Comparison between connective tissue graft and xenogeneic acellular dermal matrix to treat single gingival recession: A data reanalysis of randomized clinical trials

    by Manuela Maria Viana Miguel, Laís Fernanda Ferreira Ferraz, Amanda Rossato, Tuana Mendonça Faria Cintra, Ingrid Fernandes Mathias‐Santamaria, Mauro Pedrine Santamaria

    Objectives: There are few studies comparing xenogeneic acellular dermal matrixes (XDMs) with connective tissue graft (CTG) to treat single gingival recession (GR). The present study involved a reanalysis of previous studies and comparison of CTG or XDM to treat single RT1/GR.Materials and methods: Fifty patients from three previous randomized clinical trials treated either by CTG (n = 25) or XDM (n = 25) were evaluated after 6‐month. Clinical, patient‐centered, and esthetic parameters were assessed. Pearson's correlation and regression analyses were also performed.Results: Greater recession reduction (RecRed), percentage of root coverage (%RC), and complete root coverage (CRC) were observed in the CTG group (p ≤ 0.02). Gingival thickness (GT) and keratinized tissue width (KTW) gains were higher in the CTG group. The CTG group showed better esthetic at 6‐month. Logistic analyses reported that GT([OR] = 1.6473) and papilla height (PH) (OR = 8.20) are predictors of CRC. GT*XDM interaction was a negative predictor of CRC (OR = 7.105−5). GT at baseline acted as a predictor of RecRed in both groups (p = 0.03). The XDM graft impacted RecRed and %RC negatively. Baseline PH was a predictor of %RC for both grafts.Conclusion: CTG was superior for treating RT1/GR, providing better root coverage outcomes and tissue gains over time. GT, PH, and graft type were classified as predictors of CRC.Clinical significance: CTG presented better outcomes to treat single RT1 gingival recession when compared to the XDM.